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Abstract
Transplanting human gut microbiotas into germ-free (GF) mice is a popular approach to disentangle cause-and-effect 
relationships between enteric microbes and disease. Algorithm development has enabled sequence variant (SV) identification 
from 16S rRNA gene sequence data. SV analyses can identify which donor taxa colonize recipient GF mice, and how SV 
abundance in humans is replicated in these mice. Fecal microbiotas from 8 human subjects were used to generate 77 slurries, 
which were transplanted into 153 GF mice. Strong correlations between fecal and slurry microbial communities were 
observed; however, only 42.15 ± 9.95% of SVs successfully transferred from the donor to the corresponding recipient 
mouse. Firmicutes had a particularly low transfer rate and SV abundance was poorly correlated between donor and recipient 
pairs. Our study confirms human fecal microbiotas colonize formerly GF mice, but the engrafted community only partially 
resembles the input human communities. Our findings emphasize the importance of reporting a standardized transfer rate and 
merit the exploration of other animal models or in silico tools to understand the relationships between human gut microbiotas 
and disease.
Introduction
The gut microbiota’s role in human health and energy balance
has been widely investigated since it was posited that this
complex microbial community influences body fat regulation
[1]. Elucidating the functional role of gut microbial commu-
nities in the initiation and maintenance of disease is a critical
first step towards developing novel, effective therapies for gut
microbiota-associated diseases. Although numerous associa-
tions between altered enteric microbial community composi-
tions and human diseases have been reported [2–8], it has
been challenging to demonstrate specific disease-associated
enteric microbes as etiological agents. An attractive approach
for determining causal relationships between the intestinal
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microbiota and specific diseases is to transfer viable human
fecal microbial communities into germ-free (GF) mice (mice
born and living in the absence of microorganisms). Seminal
studies have demonstrated that transplanting fecal microbiotas
from obese individuals into GF mice results in increased
mouse adiposity compared to GF mice colonized with fecal
microbiotas from lean individuals [9, 10]. Multiple groups
have also demonstrated that transplantation of fecal microbial
communities from humans into GF or antibiotic-treated mice
transmits specific phenotypes or metabolic profiles [9–14].
Investigations using the gnotobiotic approach have
reproducibly demonstrated that the transplanted human
fecal microbiotas differ from those of specific pathogen-free
(SPF) mice [11, 15, 16]. However, these studies and others
have also reported that the enteric microbial community in
recipient mice is substantially different from that of the
human donors [11, 12, 15, 16]. Depending on the taxo-
nomic level and the computational methods used to measure
similarity, 20–88% of the human donor gut microbiota has
been reported to colonize the gastrointestinal (GI) tract of
GF or antibiotic-treated rodents after transplantation
[11, 12, 15–18]. Multiple factors likely contribute to this
extensive variation of colonization, including strong selec-
tion pressure from the host (genetic effect) [19, 20], cage
and isolator effects [12, 21, 22], and different technical
approaches to fecal transplantation [23].
Recent improvements in bioinformatic pipelines have
increased the resolution of variant classification that can
be reliably generated from 16S rRNA gene sequence data
[24–26]. Utilizing these methods, it is possible to resolve
sequence variants (SVs) to separate exact 16S rRNA gene
sequences from sequencing errors. In the current study,
we sought to utilize these recent advances in algorithm
development to achieve a high-resolution view of
microbial colonization dynamics and address important
questions regarding human fecal transfer into GF mice.
First, we calculated the transfer efficiency of the original
donor microbial community into GF mice by measuring
the presence of enteric microbial communities in (i)
human fecal samples, (ii) slurries used for colonization,
and (iii) mouse fecal pellets. Moreover, the large number
of recipient male and female GF mice colonized with each
donor sample allowed us to consider not only the pro-
portion of taxa shared between human donors and mouse
recipients, but also to directly compare the relative
abundance of each taxon between paired human
donors and mouse recipients over the course of 28 days
following colonization. In addition, as the relative abun-
dance of taxa is influenced by environmental factors (e.g.,
diet) [27] we colonized GF mice with fecal samples from
patients with anorexia nervosa (AN) at two-time points
and analyzed mouse fecal microbiotas at multiple time
points. Our study, therefore, presents a detailed picture of
how human fecal microbial communities longitudinally




Human fecal sample collection was approved by the Bio-
medical Institutional Review Board of the University of
North Carolina (UNC) at Chapel Hill. All human partici-
pants provided written consent before study participation.
All animal studies were approved by the Institutional Ani-
mal Care and Use Committee of UNC–Chapel Hill.
Human study participants
Adult female patients with AN (n= 4) and age-, race-, and
sex-matched healthy controls (n= 4) consented to partici-
pate in this study. Patients met DSM-5 criteria for AN [28]
and were recruited as inpatients from the Center of Excel-
lence for Eating Disorders at UNC–Chapel Hill. Healthy
controls were recruited using university flyers and listservs
and had no history of either a body mass index outside
18.5–24.9 kg/m2 or an eating disorder. Exclusion criteria
were applied as previously described [29]. These criteria
focused on factors known to influence the composition of
the gut microbiota including: (i) history of GI tract surgery
(other than cholecystectomy); (ii) history of inflammatory
bowel diseases, irritable bowel syndrome, celiac disease, or
any other diagnosis that could explain chronic or recurring
bowel symptoms; (iii) treatment in the previous 2 months
with antibiotics, nonsteroidal anti-inflammatory drugs, or
steroids; and (iv) intentional use of probiotics in the pre-
vious 2 months.
Human fecal sample collection
Patients with AN provided a fecal sample at time of admis-
sion to the eating disorders unit (T1) and at time of discharge
after weight restoration (T2). Once a patient had collected a
fecal sample it was placed at 4 °C until it could be transported
to the laboratory. Healthy controls provided a single fecal
sample. Healthy controls collected each sample at home using
a stool collection kit as previously described [30] and stored at
4 °C until they were shipped overnight with ice packs to our
laboratory. Fresh fecal samples arrived at the laboratory on ice
and were immediately mechanically homogenized with a
spatula in a biological safety cabinet under aerobic condi-
tions, aliquoted into 2-mL cryovials without any added
cryoprotectants and stored at −80 °C until needed for trans-
plantation into GF mice.
Transplant of human fecal microbiotas into GF mice
Sterile Dulbecco’s phosphate-buffered saline (PBS) was
prereduced by placing in an anaerobic chamber overnight to
remove oxygen. 10% (w/v) of freshly thawed human feces
was suspended in prereduced PBS under anaerobic condi-
tions and fecal slurries were vortexed for 5 min [18]. Sus-
pended bacteria were separated from fibrous material either
by centrifugation at 1000 × g for 3 min or 9 × g for 3 min, or
by filtration through a sterile 100 μm filter. The resulting
slurries were aliquoted (300 μL) into individual cryotubes
under anaerobic conditions. 8–9-week-old adult male and
female C57BL/6 GF mice were randomized into blinded
groups and orally gavaged once with 10 mL/kg (250 μL
maximum) slurry. As the efficiency of engraftment of
microbiotas into male or female mice was uncertain, both
sexes were used in our study. To avoid cage effects on the
intestinal microbiota, mice were singly housed in indivi-
dually ventilated cages with ad libitum access to autoclaved
water and rodent chow. Mice were placed into clean cages
with autoclaved bedding, hut, nestlet, water, and food every
14 days. Mice were handled under sterile flow hoods and
animal handler’s gloves were disinfected with Virkon S
between mice to collect fresh fecal pellets, body weights,
and food consumption every 7 days. 28 days after coloni-
zation, mice were euthanized with CO2 followed by cervical
dislocation.
Microbiota analysis
Genomic microbial DNA from human fecal samples,
slurries, and mouse fecal pellets was isolated via a phenol-
chloroform extraction method combined with a bead-
beating step using 0.1 mm glass beads (Bio Spec products,
Bartlesville, OK) to physically disrupt bacterial cells and a
DNA clean-up kit (Qiagen DNeasy Blood and Tissue
extraction kit, Valencia, CA) as previously described [31].
Fecal microbiotas and slurries were characterized by
creating sequencing libraries from the variable 4 (V4)
region of the 16S rRNA gene (515–806 bp) using poly-
merase chain reaction (PCR) and sequencing on the Illu-
mina MiSeq platform (Illumina, San Diego, CA) at the
High-Throughput Sequencing Facility in the Carolina
Center for Genome Sciences at the UNC School of
Medicine as previously described [32]. Mock microbial
communities (MMCs, ZymoBIOMICS™, Tustin, CA)
with known bacterial DNA were used as a defined refer-
ence for PCR and sequencing to detect potential con-
taminants. MMCs included genomic DNA from
Pseudomonas aeruginosa, Escherichia coli, Salmonella
enterica, Lactobacillus fermentum, Enterococcus faecalis,
Staphylococcus aureus, Listeria monocytogenes, and
Bacillus subtilis. For quality control, PhiX was spiked
into Illumina MiSeq runs at a range of 6.62–15.56%
(reads that matched PhiX genome were removed using
filterAndTrim function in DADA2). Q30 for all runs was
100% with cluster density ranging between 609 and
1,296 per mm2 and a passing filter ranging between
82.9–96.2%. Sequence reads were demultiplexed using an
automatic bioinformatics pipeline “BioLockJ” (https://
github.com/msioda/BioLockJ). Mock communities were
found close to their expected concentrations and genera
not expected to be present were found at low relative
abundance (Supplementary Fig. 1). Forward reads were
used for the downstream analyses. Primers from the for-
ward reads were removed by custom Java code. The
DADA2 pipeline was used to generate SVs at 100%
identity threshold. Sequences were truncated to 200 bases.
Sequences with Ns and with expected errors higher than 2
were discarded using filterAndTrim function in DADA2.
After removing 1 human fecal sample, 1 slurry, and 7
mouse fecal pellets that did not meet sequence quality, the
final number of reads was 41,090,870 (59,208.75±
32,557.47 per sample) and total number of SVs generated
by DADA2 was 2,157. Read counts were normalized
using the following formula:
log10
Raw count in sample ið Þ




SVs that were present in fewer than 10% of samples
were removed prior to any statistical analyses, resulting
in the final number of 279 SVs. Taxonomic classification
was performed using DADA2 formatted reference data-
bases (silva_nr_v128_train_set.fa.gz and silva_specie-
s_assignment_v128.fa.gz) and assignTaxonom and
addSpecies functions in DADA2. All sequences have been
deposited in NCBI Sequence Read Archive
(PRJNA558494), and all scripts are available at https://
github.com/FarnazFouladi/MicrobiotaTransfer.
Rate of SV transfer from humans to GF mice
In order to determine the rate of SV transfer from human
donors to GF mice during the colonization process, we
compared the presence of SVs between (i) the human fecal
samples and their corresponding slurries; and (ii) the slur-
ries and their corresponding fecal pellets from the recipient
GF mice. To first determine the probabilities (frequencies)
of each SV being shared between both human fecal sam-
ples and slurries, being detected only in human fecal
samples, or only being detected in slurries, we used the
following formulas:
pshared
¼ number of times that a SVwas observed in a human fecal sample and its paired slurry
final number of human fecal sample slurry pairs ðn ¼ 63Þ
ponly in human feces
¼ number of times that a SVwas observed in a human fecal sample but not in its paired slurry
final number of human fecal sample slurry pairs ðn ¼ 63Þ
ponly in slurries
¼ number of times that a SVwas observed in a slurry but not in its paired human fecal sample
final number of human fecal sample slurry pairs ðn ¼ 63Þ
Similarly, the probabilities of each SV being shared
between slurries and mouse fecal pellets, only being
detected in slurries, or only being detected in mouse fecal
pellets were determined using the following formulas:
pshared
¼ number of times that a SVwas observed in a slurry and its pairedmouse fecal pellet
final number of slurrymouse fecal pellet pairs ðn ¼ 135Þ
ponly in slurries
¼ number of times that a SVwas observed in a slurry but not in its pairedmouse fecal pellet
final number of slurrymouse fecal pellet pairs ðn ¼ 135Þ
ponly inmouse fecal pellets
¼ number of times that a SVwas observed in amouse fecal pellet but notin its paired slurry
final number of slurry mouse fecal pellet pairs ðn ¼ 135Þ
Statistical tests
A nonparametric Spearman’s rank-order correlation was
used to study the relationship between SVs in human fecal
samples, slurries, and mouse fecal pellets. All p values from
Spearman correlations were corrected for multiple
hypothesis testing using the Benjamini–Hochberg proce-
dure with a threshold false discovery rate (FDR) of 0.05.
The ADONIS test, a permutation-based multivariate
ANOVA using Bray–Curtis dissimilarity matrices, was
used to compare the fecal microbiota composition between
samples. One-way ANOVA with a post-hoc Tukey’s
Honestly Significant Difference (HSD) test was used to
compare the transfer efficiency of SVs between different
taxonomic groups in recipient GF mice. Adjusted p values
less than 0.05 were considered significant.
Results
This study used 12 human donor fecal samples for coloni-
zation experiments (4 healthy controls and 4 patients with
AN before and after clinical renourishment). For each
human donor, 3–7 slurries were prepared for independent
colonization experiments. While we used both 100 μM cell
strainers and centrifugation to remove fecal debris, our
analyses demonstrate that preparation method did not have
a significant effect on transfer efficiency of microbes from
slurries into recipient GF mice (Supplementary Fig. 2). For
each freshly prepared slurry, 1–4 C57BL/6 GF mice were
colonized. In sum, this study used 12 fecal samples pro-
vided by 8 human donors for colonization of 153 GF mice
using 77 different slurries (Table 1A, B).
Fecal pellets were collected from mice once every 7 days
following colonization and mice were followed for 28 days
(4 time points per mouse). Based on Bray–Curtis dissim-
ilarity matrices, we observed distinct clustering between
mouse and human samples, with human fecal samples and
slurries clustering together (ADONIS test, r2= 0.11,
p value= 0.001; Fig. 1a). Although forward reads were
used for analysis, paired reads generated comparable data
(Supplementary Fig. 3a). The transplanted microbial com-
munity was stable over the 4-week colonization period
Table 1 Number of biological
samples generated, collected,
and analyzed in this study. A)
Number of human slurries
generated and mouse fecal
samples collected. B) Number of
human slurries and mouse fecal
samples analyzed after removing
samples that were not sequenced
or failed to meet sequencing
quality thresholds.
Human participants HC_1 HC_2 HC_3 HC_4 AN_5 AN_6 AN_7 AN_8 SUM
Timepoint T1 T2 T1 T2 T1 T2 T1 T2
A. Number of samples collected in the study
Slurries 6 7 6 6 6 6 7 8 6 6 7 6 77
Recipient mice 12 14 12 12 12 12 14 17 12 12 12 12 153
Mouse fecal pellets (4 timepoints) 48 56 48 48 48 48 56 68 48 48 48 48 612
B. Number of samples analyzed after removing samples that failed to meet sequencing quality
thresholds
Slurries 6 3 6 6 6 6 5 5 6 6 7 6 68
Recipient mice 12 14 12 12 12 12 14 17 12 12 12 12 153
Mouse fecal pellets (4 timepoints) 47 55 48 48 48 48 56 66 47 48 48 46 605
(Supplementary Fig. 4). In addition, the clustering patterns
were dependent on the identity of the human donors
(Fig. 1b; Supplementary Fig. 3b for paired read analysis).
Human fecal samples and slurries explained 69.9% and
80.61% of variance, respectively, in mouse fecal micro-
biotas (ADONIS test, p value= 0.001). Our data are
therefore consistent with previous studies reporting that the
input of the human microbial community has a profound
impact on the resulting microbial community in the colo-
nized rodent [11, 15–17].
Slurries adequately represent microbial
communities in human fecal samples
To determine the retention of gut microbiota when prepar-
ing slurries from human fecal samples, we calculated the
presence of unique SVs in both human fecal samples (n=
11) and the corresponding slurries (n= 63). The number of
human fecal samples and slurries is based on the number of
available samples with 16S rRNA gene sequencing data. A
non-paired analysis (i.e., SVs were detected in at least 1
human fecal sample and 1 slurry) showed that 88.39% of
SVs were shared between human fecal samples and slurries
(Fig. 2a; Supplementary Fig. 5a for paired read analysis),
which was not influenced by sequence depth (Supplemen-
tary Figs. 6, 7a, c) or filtering threshold (Supplementary
Fig. 8a). However, a paired analysis (i.e., SVs must be
present in the human fecal sample and its corresponding
slurry) showed that on average 71.85 ± 7.64% of SVs were
shared between a human fecal sample-slurry pair with
13.88 ± 9.78% of SVs found only in the slurry and 14.27 ±
9.59% of SVs found only in the human fecal sample
(Fig. 2b; Supplementary Fig. 5b for paired read analysis).
As predicted, the frequency of SVs shared between human
fecal sample-slurry pairs was strongly associated with the
rank abundance of each SV, with more abundant SVs in
human fecal samples having a greater probability of being
present in the respective slurries (Fig. 2c; Supplementary
Fig. 5c for paired read analysis). However, SVs that were
detected only in human fecal samples or only in slurries did
not have an obvious relationship to the overall rank abun-
dance of the SVs in the human fecal samples (Fig. 2d, e;
Supplementary Fig. 5d, e for paired read analysis). Overall,
these data demonstrate that relatively abundant micro-
organisms are successfully retained during preparation of
slurries from human fecal samples.
In addition to investigating whether SVs were observed
in paired samples, we directly compared the relative abun-
dance of all 279 SVs for each of the 63 human fecal sample-
slurry pairs. Reassuringly, there was a strong correlation
between relative abundances of SVs detected in a human
fecal sample and its paired slurry (n= 63 human fecal
sample-slurry pairs, Spearman’s correlation coefficient (ρ)
= 0.77 ± 0.15), suggesting that community composition
was strongly preserved between paired human feces and
slurries (Fig. 3a, b; Supplementary Fig. 9; Supplementary
Fig. 10a, b for paired read analysis).
Mouse fecal pellets only partially represent the
microbial communities from slurries
Using the same approach as the human fecal sample-slurry
analysis, we compared SVs in 135 slurry-mouse fecal pellet
pairs. A non-paired analysis (i.e., SVs were present in at
least 1 slurry and mouse fecal pellet) showed that 95.34% of






















































Fig. 1 Multidimensional scaling of microbial communities from
human fecal samples, slurries, and mouse fecal pellets. a Multi-
dimensional scaling of microbial composition from human fecal
samples, slurries, and mouse fecal pellets color coded by sample type.
b Multidimensional scaling of microbial composition from human
fecal samples, slurries, and mouse fecal pellets color coded by human
donors. HC healthy control, T1 patient with anorexia nervosa before
clinical renourishment, T2 patient with anorexia nervosa after clinical
renourishment, MDS multidimensional scaling. Each number in the
Donors legend identifies a unique donor.
pellets at week 1 post colonization. However, a paired
analysis (i.e., SVs must be present in the slurry and the
corresponding mouse fecal pellet) found that only 42.15 ±
9.95% SVs were shared between a slurry-mouse fecal pellet
pair, with a significant number of SVs detected only in the
slurry (32.57 ± 11.67%) or only in the mouse fecal pellet
(25.28 ± 10.11%) at week 1 post colonization (Fig. 4a, b).
The percent of SVs shared between human slurries and
mouse fecal samples was not influenced by sequencing
depth (Supplementary Fig. 7b, d) or when pairing forward
and reverse sequence reads (Supplementary Fig. 11a, b);
however, a lower filtering threshold decreased the percent
of SVs shared between human slurries and mouse fecal
samples (Supplementary Fig. 8b). In addition, the percent of
SVs shared between slurry-mouse fecal pellet pairs was not
influenced by sex of the recipient mouse (Supplementary
Fig. 12) and did not substantially change over the 4-week
colonization period (Supplementary Figs. 13 and 14).
Similar to findings from the human fecal sample-slurry
analysis, SVs with a higher rank abundance in slurries were
more likely to be successfully transferred into mice; how-
ever, 32 SVs with rank abundance of higher than 200 in
slurries had a transfer rate less than 25% (dashed square in
Fig. 4c, e; Supplementary Table 1; Supplementary Fig. 11c,
e for paired read analysis). These SVs were significantly
over- and under-represented by the Firmicutes and Bacter-
oidetes phyla, respectively, compared with the other high-
abundance taxa that had a transfer rate of more than 25%
(Fisher’s exact test, Firmicutes p value < 0.001; Bacter-
oidetes p value < 0.01). These SVs mostly belonged to the
families Streptococcaceae, Lachnospiraceae, Rumino-
coccaceae, Veillonellaceae, Erysipelotrichaceae, Peptos-
treptococcaceae, and Family_XIII.
Surprisingly, 41 SVs were found in more than 33 mouse
fecal pellets but not in their paired slurries (dashed square in
Fig. 4d; Supplementary Fig. 11d for paired read analysis).
90% of these 41 SVs were of low abundance in the entire
set of slurries (rank abundance below 200) and belonged to
the Firmicutes (n= 37), Bacteroidetes (n= 2), Proteo-
bacteria (n= 1), and Actinobacteria (n= 1) phyla,
Fig. 2 Retention of SVs from human stool in slurries. a Percent of
SVs that were detected in at least 1 human fecal sample and 1 slurry
(shared: 88.39%), detected in at least 1 human fecal sample but not in
any slurry (only in human fecal samples: 0.75%), detected in at least
1 slurry but not in any human fecal sample (only in slurries: 10.86%).
b Average percentages of SVs that were detected in a human fecal
sample-slurry pair (shared: 71.85 ± 7.64%), detected in the human
fecal sample but not the respective slurry (only in human fecal sample:
14.27 ± 9.59%), detected in the slurry but not in the respective human
fecal sample (only in slurry: 13.88 ± 9.78%). Data are presented as
mean ± standard deviation. c Relationship between the probability of
SVs being shared between human fecal sample-slurry pairs and rank
abundance of SVs in human fecal samples. d Relationship between the
probability of SVs being detected in slurries but not in their paired
human fecal sample and rank abundance of SVs in human fecal
samples. e Relationship between the probability of SVs detected in
human fecal sample but not in their paired slurries and rank abundance
of SVs in human fecal samples. SV sequence variant.
(Supplementary Table 2). At the family level, these SVs
belonged to Bacteroidaceae, Coriobacteriaceae, Rumino-
coccaceae, Lachnospiraceae, Eubacteriaceae, Enter-
obacteriaceae, and Erysipelotrichaceae.
For each of the 135 mouse fecal pellet-slurry pairs, we
directly compared the relative abundance of all 279 SVs in
both environments. In contrast to the strong positive cor-
relation between human fecal samples and slurries, the
relative abundance of SVs was largely negatively
correlated between slurries and mouse fecal pellets (mean
ρ=−0.20 ± 0.12) with 66 of the 135 pairs showing a sta-
tistically significant negative relationship at a 5% FDR
threshold (Fig. 5a, b, Supplementary Fig. 15; Supplemen-
tary Fig. 16a, b for paired read analysis). These negative
correlations were not sex-dependent (Supplementary
Fig. 17) and were largely due to the abundance of several
human fecal taxa being poorly represented in mouse fecal
pellets or, conversely, taxa enriched in mouse fecal pellets
that were not detected in the paired slurries. The associa-
tions between human slurries and mouse fecal microbial
communities remained the same at weeks 1, 2, 3, and 4 post
colonization (Supplementary Fig. 18a).
Most SVs in mouse fecal pellets show modest
positive correlations with paired human fecal
microbiota communities
Up to this point, our analyses compared the relative
abundance of all SVs in human feces, slurries, and mouse
fecal pellets for each paired sample (63 human fecal
sample-slurry pairs and 135 slurry-mouse fecal pellet
pairs). In order to better estimate the transfer efficiency
for each individual SV, we determined the association
between the relative abundance of each of the 279 SVs
across all 135 slurry-mouse fecal pellet pairs. Using this
approach, we found that 69% of SVs were positively
correlated between slurries and mouse fecal pellets at
week 4 post colonization at 5% FDR (range of sig-
nificantly positive ρ= 0.18–0.99, Table 2, Supplementary
Table 3, Supplementary Fig. 18b, and Supplementary
Fig. 19). These mostly modest correlations between
slurries and mouse fecal pellets were not strong enough to
result in similar overall microbial community composi-
tion between paired slurries and mouse fecal pellets, as
shown in Fig. 5.
Fig. 3 Relationship between relative abundance of SVs in a human
fecal sample-slurry pairs. a Spearman’s rank-order correlations for
each paired donor fecal-slurry sample (n= 63 paired fecal-slurry
samples). p values were adjusted using the Benjamini–Hochberg (BH)
procedure. x- and y-axes are log10-normalized relative abundance of
SVs. Plots for all paired human fecal sample-slurry pairs are included
in Supplementary Fig. 9. b Boxplots showing Spearman correlation
coefficients (rho: ρ) between human fecal sample-slurry pairs for each
donor (n= 3–7 human fecal sample-slurry pairs per donor). HC
healthy control, T1 patient with anorexia nervosa before clinical
renourishment, T2 patient with anorexia nervosa after clinical
renourishment, SV sequence variant.
Abundant members of Firmicutes fail to reliably
transfer from slurries to mice
To compare transfer efficiency of different taxa from slur-
ries to GF mice, we compared Spearman correlation coef-
ficients (ρ) of SVs between different taxonomic
classifications (Fig. 6a, Supplementary Fig. 20a–d). SVs
belonging to the Bacteroidia class (ρ= 0.65 ± 0.25) estab-
lished more efficiently in mice compared with other taxo-
nomic classes, such as Clostridia (ρ= 0.30 ± 0.27) and
Erysipelotrichia (ρ= 0.28 ± 0.31) at week 4 post coloniza-
tion (Supplementary Fig. 20b). At the family level, Bac-
teroidaceae (ρ= 0.66 ± 0.28), Porphyromonadaceae (ρ=
0.70 ± 0.22), and Prevotellaceae (ρ= 0.76 ± 0.07) had sig-
nificantly greater Spearman correlation coefficients com-
pared with Erysipelotrichaceae (ρ= 0.28 ± 0.31),
Lachnospiraceae (ρ= 0.26 ± 0.27), and Ruminococcaceae
(ρ= 0.31 ± 0.27) at week 4 post colonization (Supplemen-
tary Fig. 20d). Consistent with previous results [11, 15–17],
these data suggest that taxa belonging to Bacteroidetes have
greater transfer efficiencies from human fecal samples to
mice compared with members of the Firmicutes phylum.
As we observed a stronger human-mouse correlation for
SVs belonging to Bacteroidetes compared with Firmicutes,
we next compared the Firmicutes to Bacteroidetes ratio
between human feces, slurries, and mouse fecal pellets.
Mouse fecal pellets had the lowest Firmicutes to Bacter-
oidetes ratio (log10 Firmicutes:Bacteroidetes= 0.32 ± 0.26,
Fig. 6b), whereas human fecal samples had the highest
Firmicutes to Bacteroidetes ratio (log10 Firmicutes:Bacter-
oidetes= 2.05 ± 0.66, Fig. 6b), further supporting that
Bacteroidetes originating from human fecal samples colo-
nize GF mice more efficiently than Firmicutes.
Discussion
A major challenge for current intestinal microbiota research
is moving from observational to mechanistic studies that
reveal how members of these complex microbial
Fig. 4 Retention of SVs from slurries in recipient mice. a Percent of
SVs that were detected in at least 1 slurry and 1 mouse fecal pellet
(shared: 95.34%), detected in at least 1 slurry but not in any mouse
fecal pellet (only in slurries: 0.72%), detected in at least in 1 mouse
fecal pellets but not in any slurry (only in mouse fecal pellets: 3.94%)
1 week after colonization. b Average percentages of SVs that were
detected in a slurry-mouse fecal pellet pair (shared: 42.15 ± 9.95%),
detected in the slurry but not in the respective mouse fecal pellet (only
in slurry: 32.57 ± 11.67%), detected in the mouse fecal pellet but not in
the respective slurry (only in mouse fecal pellet: 25.28 ± 10.11%)
1 week after colonization. Data are presented as mean ± standard
deviation. c Relationship between the probability of SVs being shared
between slurry-mouse fecal pellet pairs and rank abundance of SVs in
slurries 1 week after colonization. d Relationship between the prob-
ability of SVs detected in mouse fecal pellets but not in their paired
slurries and rank abundance of SVs in slurries 1 week after coloni-
zation. e Relationship between the probability of SVs detected in
slurries but not in their paired mouse fecal pellets and rank abundance
of SVs in slurries 1 week after colonization. SV sequence variant.
Table 2 Representative SVs that were efficiently transferred from slurries to recipient mice 4 weeks after colonization.
Sequence variant Rho coefficient p value Phylum Family Genus
SV82 0.99 5.20E−110 Bacteroidetes Porphyromonadaceae Parabacteroides
SV121 0.99 5.02E−104 Firmicutes Ruminococcaceae Ruminococcaceae_UCG-009
SV331 0.98 2.72E−94 Firmicutes Lachnospiraceae Lactonifactor
SV405 0.96 9.54E−76 Bacteroidetes Porphyromonadaceae NA
SV66 0.96 1.78E−73 Bacteroidetes Bacteroidaceae Bacteroides
SV446 0.93 4.57E−57 Firmicutes Ruminococcaceae Anaerofilum
SV30 0.93 3.98E−56 Bacteroidetes Bacteroidaceae Bacteroides
SV277 0.92 2.28E−53 Actinobacteria Coriobacteriaceae NA
SV100 0.92 2.28E−53 Bacteroidetes Bacteroidaceae Bacteroides
SV109 0.91 5.21E−51 Bacteroidetes Bacteroidaceae Bacteroides
SV127 0.91 6.48E−51 Firmicutes Erysipelotrichaceae Dielma
SV81 0.90 1.00E−48 Bacteroidetes Bacteroidaceae Bacteroides
SV274 0.89 5.68E−47 Proteobacteria Desulfovibrionaceae Desulfovibrio
SV578 0.88 5.41E−44 Firmicutes Defluviitaleaceae Defluviitaleaceae_UCG-011
SV87 0.87 1.21E−41 Bacteroidetes Bacteroidaceae Bacteroides
SV271 0.85 2.89E−37 Bacteroidetes Porphyromonadaceae Butyricimonas
SV75 0.84 1.88E−36 Bacteroidetes Rikenellaceae Alistipes
SV154 0.83 4.65E−34 Firmicutes Ruminococcaceae NA
SV10 0.82 1.82E−33 Bacteroidetes Prevotellaceae Prevotella_9
SV172 0.82 1.14E−32 Firmicutes Ruminococcaceae Anaerofilum
SV201 0.82 1.83E−32 Firmicutes Ruminococcaceae Ruminiclostridium_9
SV74 0.82 2.63E−32 Bacteroidetes Rikenellaceae Alistipes
SV46 0.81 1.67E−31 Firmicutes Lachnospiraceae Lachnoclostridium
Transfer efficiency is represented by significant (adjusted p value < 0.05) Spearman correlation coefficients (rho: ρ) for each SV across 135 slurry-
mouse fecal pellet pairs 4 weeks after colonization. This table shows the first 23 SVs with the highest transfer efficiency (rho coefficients >0.80).
Other SVs with significant transfer efficiency are included in Supplementary Table 3. SV sequence variant, NA unclassified.
Fig. 5 Relationship between relative abundances of SVs in a slurry-
mouse fecal pellet pairs 1 week after colonization. a Spearman’s
rank-order correlations for each slurry-mouse fecal pellet pair (n= 135
slurry-mouse fecal pellet pairs). p values were adjusted using the
Benjamini–Hochberg (BH) procedure. x- and y-axes are log10-normalized
relative abundance of SVs. Plots for all slurry-mouse fecal pellet pairs are
included in Supplementary Fig. 15. b Boxplots showing Spearman cor-
relation coefficients (rho: ρ) between slurry-mouse fecal pellet pairs for
each slurry 1 week after colonization (n= 1–4 paired slurry-mouse fecal
pellet samples per slurry). HC healthy control, T1 patient with anorexia
nervosa before clinical renourishment, T2 patient with anorexia nervosa
after clinical renourishment, SV sequence variant.
communities impact host physiology. GF mice colonized
with fecal microbiotas remain one of the most appealing
models to determine the impact of a disease-associated gut
microbiota on the host. As part of our ongoing research
interested in understanding the link between the human gut
microbiota and its influence on metabolic aspects of AN we
were motivated to investigate the efficiency of transplanting
human fecal microbiotas into GF mice. Using a large
sample size of gnotobiotic mice that resulted from these
studies, we here report the results of identifying SVs from
high-throughput 16S rRNA gene sequencing to generate a
high-resolution picture of the transfer efficiency of human
fecal microbial communities into GF mice. Consistent with
previous studies, we found that the introduction of human
fecal microbiotas into a GF mouse results in distinct clus-
tering patterns that are dependent on the identity of the
human donor. Our findings also demonstrated that slurries
prepared from human fecal samples adequately reflected the
donor source microbiota. Conversely, on average, only 42%
of SVs transferred from slurries to the corresponding GF
mice, and the relative abundances of several human fecal
taxa in the slurries were poorly represented in the mouse
fecal pellets, and vice versa. Indeed, the presence of a few
high-abundance taxa in the slurries that were absent in the
mice led to weak, but statistically significant, negative
correlations in taxa for many of the paired samples between
mice and their respective slurries. While untangling the
underlying biological factors responsible for the observed
poor transfer efficiency is beyond the scope of our study,
possible explanations have been discussed in detail in a
review by Arrieta et al. [20]. Some of these potential factors
include the differences in GI anatomy and physiology
between humans and mice, poor immune development in
GF mice, and the drastic change in diet that microbial
communities are exposed to when transplanted from
humans to GF rodents.
Interestingly, consistent with other studies [11, 15–17],
we found members of the Bacteroidetes phylum had greater
colonization efficiency in GF mice than members of the
Firmicutes phylum. We also found SVs that were detected
only in mouse fecal pellets when compared with their cor-
responding slurries. There are two possible explanations for
phenomenon; (i) these SVs may have been present in the
slurries at abundances below 16S rRNA gene sequencing
detection limits and then flourished upon entering a sterile
GI tract, or (ii) these SVs may have been introduced into
recipient mice from the environment. Given that the tax-
onomy of these SVs encompass typical enteric microbes
and not microbes from human or environmental niches
(e.g., microbes from the skin), we believe the former option
to be more likely. It is more difficult to explain the origin of
SVs found only in slurries and not present in their corre-
sponding human fecal samples (13.88 ± 9.78% of all SVs in
human fecal sample-slurry pairs). It is possible that these
SVs are a result of environmental contamination as slurries
were prepared in a clean, but non-sterile, anaerobic cham-
ber. Given the importance of mirroring the composition of
donor gut microbiotas in corresponding mouse recipients,
reporting a standardized transfer rate in current and future
GF colonization studies is critical. Transfer efficiency is
Fig. 6 Transfer efficiency across different bacterial taxa. a Boxplots
showing transfer efficiency of SVs in slurries to recipient GF mice at the
phylum level 4 weeks after colonization. Transfer efficiency is repre-
sented by the Spearman correlation coefficients (rho: ρ) for each SV
across slurry-mouse fecal pellet pairs. Number of SVs in each phylum:
12 Actinobacteria, 39 Bacteroidetes, 211 Firmicutes, 7 Proteobacteria, 2
Verrucomicrobia, 1 Unclassified (NA). b log10 normalized Firmicutes to
Bacteroidetes ratio in human fecal samples, slurries, and mouse fecal
pellets. One-way ANOVA with a post-hoc Tukey’s HSD, ***adjusted
p value < 0.001, **adjusted p value < 0.01. SV sequence variant.
frequently reported by examining the fraction of operational
taxonomic units or SVs present in the human donor samples
that is also present in any of the mouse samples. Our results
argue that this “unpaired” approach overstates the true
transfer efficiency and should be avoided. We propose an
alternative method to calculate transfer efficiencies between
paired samples (i.e., human donor and corresponding mouse
recipient samples) to more accurately reflect the percent of
SVs, and their relative abundances, that successfully engraft
in the recipient mouse.
This study also had limitations that should be noted.
Importantly, we calculated transfer efficiencies using high-
throughput sequencing of the 16S rRNA gene and therefore
cannot differentiate between viable and non-viable
microbes in the human fecal samples. Therefore, it is
possible that our calculations have underestimated the
actual rate of transfer efficiency as non-viable bacteria will
not colonize the GI tract of the recipient mouse. Secondly,
mice in this study were singly housed in ventilated cage
racks in an SPF facility, rather than in a gnotobiotic iso-
lator; however, a study using mice colonized with human
fecal microbiotas and housed in gnotobiotic isolators
reported a very similar transfer efficiency (45% of genera
and 20% of operational taxonomic units between human
donor and mouse recipient) [12]. Nevertheless, animal
housing and husbandry facilities are environmental factors
that influence the murine gut microbiota and may also
impact the transfer efficiency in gnotobiotic mouse models
[33]. Thirdly, this study profiled the microbial communities
using fecal pellets rather than cecal contents or mucosal
tissue from the small and large intestines. We preferentially
chose to analyze fecal pellets in order to investigate the
effect of time on the rodent microbial communities; how-
ever, the transfer efficiency of microbial communities
could differ if the same analysis were to be carried out
using samples from a potentially more physiologically
relevant site, such as the cecum or intestinal mucosal tissue.
Fourthly, although our approach for collecting human fecal
samples is consistent with methods used in multiple clinical
studies, the samples we assembled were held at 4 °C for up
to 24 h during transportation. While it is certainly possible
that this storage at 4 °C impacted our results, it has been
reported by multiple groups that transporting fecal samples
for up to 48 h at 4 °C has a negligible impact on microbial
communities [34–36]. Finally, although we use an estab-
lished approach for characterizing complex microbial
communities (16S rRNA gene sequencing), known PCR
and sequencing biases are inherently embedded in this
method [37, 38].
This study sheds light on an inherent limitation that
exists when human fecal microbiotas are transplanted into
GF mice. Notably, we identify a number of specific taxa
that match their abundances in the donor sample when
transplanted into GF mice. These taxa may be of clinical
relevance and therefore valuable in the design of future
studies using human fecal microbiotas and GF mice. In
addition, whole-genome and transcriptome sequencing
studies have the potential to help determine whether fecal
microbiotas are functionally altered when transplanted into
GF mice. It may also be worth performing similar compo-
sitional and functional studies in other gnotobiotic mammal
models, such as pigs, that share more anatomical features to
humans and could, therefore, provide an environmental
niche that is more accommodating to the introduction of
human microbiotas.
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